Page last updated: 2024-11-03

probucol and Kidney Failure, Chronic

probucol has been researched along with Kidney Failure, Chronic in 6 studies

Probucol: A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).
probucol : A dithioketal that is propane-2,2-dithiol in which the hydrogens attached to both sulfur atoms are replaced by 3,5-di-tert-butyl-4-hydroxyphenyl groups. An anticholesteremic drug with antioxidant and anti-inflammatory properties, it is used to treat high levels of cholesterol in blood.

Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.

Research Excerpts

ExcerptRelevanceReference

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsunaga, A1
Furuyama, M1
Hashimoto, T1
Toyoda, K1
Ogino, D1
Hayasaka, K1
Fiorini, F1
Patrone, E1
Castelluccio, A1
Naito, H1
Hirano, T1
Sia, YT1
Lapointe, N1
Parker, TG1
Tsoporis, JN1
Deschepper, CF1
Calderone, A1
Pourdjabbar, A1
Jasmin, JF1
Sarrazin, JF1
Liu, P1
Adam, A1
Butany, J1
Rouleau, JL1
Mimura, K1
Yukawa, S1
Grundy, SM1

Reviews

1 review available for probucol and Kidney Failure, Chronic

ArticleYear
Management of hyperlipidemia of kidney disease.
    Kidney international, 1990, Volume: 37, Issue:3

    Topics: Anticholesteremic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolem

1990

Trials

1 trial available for probucol and Kidney Failure, Chronic

ArticleYear
Clinical investigation on the hypolipidemic effect of simvastatin versus probucol in hemodialysis patients.
    La Clinica terapeutica, 1994, Volume: 145, Issue:9

    Topics: Aged; Combined Modality Therapy; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Kidney Failu

1994

Other Studies

4 other studies available for probucol and Kidney Failure, Chronic

ArticleYear
Improvement of nephrotic syndrome by intensive lipid-lowering therapy in a patient with lipoprotein glomerulopathy.
    Clinical and experimental nephrology, 2009, Volume: 13, Issue:6

    Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Apoli

2009
Probucol suppresses the development of chronic renal failure in Dahl salt-sensitive rats: an animal model of spontaneous focal and segmental glomerulosclerosis.
    Nephron, 1994, Volume: 67, Issue:1

    Topics: Animals; Disease Models, Animal; Glomerulosclerosis, Focal Segmental; Kidney Failure, Chronic; Lipid

1994
Beneficial effects of long-term use of the antioxidant probucol in heart failure in the rat.
    Circulation, 2002, May-28, Volume: 105, Issue:21

    Topics: Animals; Antioxidants; Apoptosis; Atrial Natriuretic Factor; Chronic Disease; Disease Models, Animal

2002
[Hyperlipidemia and drug treatment].
    Nihon rinsho. Japanese journal of clinical medicine, 1991, Volume: 49 Suppl

    Topics: Arteriosclerosis; Carnitine; Cholestyramine Resin; Glomerulonephritis; Humans; Hyperlipidemias; Kidn

1991